Pharmaceutical unit-dose repackaging and supply chain solutions company Safecor Health, a Vesey Street Capital Partners (VSCP) portfolio company, announced on Monday that it has acquired the US unit-dose packaging business of pharmaceutical company Viatris Inc (NASDAQ:VTRS).
The business was previously called Unit Dose Laboratories (UDL). Established in 1980, it provides unit-dose generic medicines to institutional and long-term care facilities.
The acquisition is expected to be finalised in the first half of 2025, with no immediate action required by customers or partners at this time.
Safecor CEO Mark Saxon, said: "Adding the UDL team, the strong brand recognition, and their capabilities to the Safecor family will further our ongoing goal of providing world-class packaging and supply chain solutions to the manufacturers and health systems we serve. With this addition, we'll immediately increase the number of unit-dose commercial products we offer, and we plan to grow the offering with expanded manufacturer, health system, and wholesaler relationships."
Esperion settles with Dr. Reddy's Laboratories on NEXLETOL and NEXLIZET generics
Mint Pharmaceuticals forms distribution partnership with Bayer Canada
Padagis collaborates with The Naloxone Project to address opioid overdose crisis
Biocon's first US manufacturing facility inaugurated in Cranbury, New Jersey
Amneal's risperidone extended-release injectable suspension approved by US FDA
First FDA acceptance to waive clinical efficacy studies for monoclonal antibody biosimilars
Coya Therapeutics wins FDA clearance to advance COYA 302 into Phase 2 ALS trial
Viatris' generic iron sucrose injection gains US FDA approval